Natan Ponieman - Spark Newswire

1 minute read

Silo Wellness Signs $3M U.S. Distribution Deal For Functional Mushroom Products

Today, 7:42 AM

Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF), a company in the psychedelics space that also sells non-psychedelic mushroom products, announced a $3 million national distribution agreement with Texas-based One Light Enterprises LLC.

CSE:SILO

1 minute read

Mydecine Innovations Inks Deal With Johns Hopkins University To Undertake Psychedelics Research Into Smoking Cessation

By Natan Ponieman

Today, 7:42 AM

Mydecine Innovations Group (NEO: MYCO) (OTCPINK: MYCOF) has signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine, to study the application of psychedelics molecules and therapies in smoking cessation.

MYCOF

6 minute read

These Seven Cannabis Companies Are Uniquely Positioned To Leverage Colombia’s New Regulations For International Exports

By Natan Ponieman

Today, 7:42 AM

Colombia began its path towards cannabis legalization in 1986, and now has one of the most advanced regulatory systems on the continent. In late July, President Iván Duque authorized the legal sale and global export of dried cannabis for medical purposes.

ALID

1 minute read

Delta 9 Cannabis Strengthens Manitoba Presence In Seventh Consecutive Quarter Of Positive EBITDA

By Natan Ponieman

Today, 7:42 AM

Delta 9 Cannabis Inc. (TSX: DN) (OTCQX: DLTNF) announced financial results for the second quarter ending June 30, 2021.

DLTNF

4 minute read

Psyched: Atai Launches ‘Salvia Divinorum’ Subsidiary, Mindset, Psilera and Wesana’s Preclinical Trials, Origin Raises $5M

By Natan Ponieman

Today, 7:42 AM

Atai Life Sciences Launches New Salvia Divinorum Subsidiary Atai Life Sciences (NASDAQ: ATAI) announced the launch of a new subsidiary that will research Salvinorin A, the active compound in salvia divinorum, a hallucinogenic herb native to Central America.

ATAI

3 minute read

Cantor Remains Neutral on Charlotte’s Web, cbdMD and CV Science, Why These CBD Stocks May Benefit If Cannabis Reform Actually Happens

By Natan Ponieman

Today, 7:42 AM

Cantor Fitzgerald released a new report analyzing the possible effects of CBD reform in the stock performance of Charlotte's Web Holdings (TSX: CWEB) (OTCQX: CWBHF), cbdMD (NYSE:

AMZN

1 minute read

Cantor: ‘Aleafia Continues To Post Solid Momentum,’ Firm Bullish But Lowers Price Target Due To Cannabis Sector Derating

By Natan Ponieman

Today, 7:42 AM

Cantor Fitzgerald issued an analysis on Aleafia Health Inc.

ALEAF

2 minute read

Cantor Is Bullish On Trulieve’s Q2 Financials, But Remains Cautious Of Possible Risks Ahead, Drops Price Target To $50

By Natan Ponieman

Today, 7:42 AM

Following financial results showing 14 consecutive quarters of profitability released by Trulieve Cannabis Corp.

CSE:CURA

2 minute read

Atai Life Sciences To Research Potent Psychedelic Herb Salvia Divinorum Through Its New Subsidiary

By Natan Ponieman

Today, 7:42 AM

Atai Life Sciences (NASDAQ: ATAI) has announced the launch of a new subsidiary that will research Salvinorin A, the active compound in salvia divinorum, a hallucinogenic herb native to Central America.

ATAI